News

Mobile app-based research platform aims to engage and empower researchers and participants across the country.

3-year observational results of novel, home-based clinical trial published in PLOS ONE

New Orleans’ Mardi Gras festival of February 2020 appears to have driven one of the worst early outbreaks of COVID-19 in the United States, according to a study led by scientists at Scripps Research.

As part of Scripps Research’s landmark DETECT study, scientists are examining physiological and behavioral changes that often last months after a COVID-19 infection. 

A grant from the New York-based foundation will fuel expansion of DETECT, Scripps Research’s sensor-based study for real-time digital detection of viral illness.    

An international team, including scientists from Scripps Research, helped find answers after a man became sick for a second time with Ebola and sparked a transmission chain of more than 90 cases.

A genetic analysis of virus samples suggests that the UK-originating variant, which is 40-50 percent more transmissible, entered the country in late November 2020.

Rapid genetic sequencing of COVID-19 virus samples isn’t enough; standardized lab tests are needed to understand potential mutations that may boost infectiousness or enable immune evasion.

Scientists will distribute 10,000 Fitbit devices in an effort to understand study participant engagement.

To drive global research efforts, the Center for Viral Systems Biology at Scripps Research is tracking the prevalence of new variants of SARS-CoV-2 and making this information publicly available.

Warning that the next fast-spreading virus may not be as accommodating as the coronavirus driving COVID-19, they call for a new approach to pandemic preparedness.  

The study will leverage genomics and digital technologies to better understand factors that contribute to obesity and type 2 diabetes. 

Topol to be honored alongside Drs. Anthony Fauci and Wayne Riley, as well as hundreds of healthcare professionals for their dedication and compassion during the COVID-19 crisis.  

Findings suggest COVID-19 testing should be expanded to those without symptoms who may be unknowingly spreading the virus to others.

Since the team's discovery, several additional cases of the B.1.1.7 coronavirus variant have been identified across California.

With funding from the Centers for Disease Control and Prevention, scientists at Scripps Research and UC San Diego are sequencing the virus to help guide local outbreak response.

Sensor data from wearable devices can complement virus testing and conventional screening to signal new infections.

Wearable devices give scientists a powerful new tool for sleep studies.

Scientists in the United States and West Africa to develop research network to rapidly respond to current and future infectious disease outbreaks.

Scripps Research is collaborating with frontline workers at the San Diego Metropolitan Transit System and Scripps Health to help detect and track viral illnesses in near real-time.

The rich data stored in electronic medical records may offer clues to better care for those diagnosed with coronavirus disease.

Analysis of data from 16 groups of COVID-19 patients suggest “silent” carriers may exacerbate efforts to stop spread of the disease

The study seeks to evaluate shared data from wearable users as part of a program to improve detection and containment of infectious disease outbreaks.

Topol was honored for his contributions in genomic and digital technologies to transform the practice of medicine.